Ortho Clinical Diagnostics Holdings plc Profit Margin

Ortho Clinical Diagnostics Holdings plc (OCDX) currently reports a profit margin of -0.02% as of April 2022. That compares with -8.03% in the prior-year period — up 99.8% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Ortho Clinical Diagnostics Holdings plc's profit margin history and peer comparisons.

Ortho Clinical Diagnostics Holdings plc's profit margin increased from -8.03% to -0.02% — a 99.8% year-over-year increase (period ending April 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ortho Clinical Diagnostics Holdings plc's profit margin of -0.02% is lower than the Healthcare sector average of 13.89%. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Ortho Clinical Diagnostics Holdings plc's current -0.02% should be judged against Healthcare norms (sector average: 13.89%) and against OCDX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -0.02%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Ortho Clinical Diagnostics Holdings plc, and consider following OCDX for alerts when major investors trade the stock.